Tuesday, December 01, 2015 7:05:41 PM
http://www.cancernetwork.com/smr-2015/low-dose-ipilimumab-pembrolizumab-reduces-toxicity-advanced-melanoma
In conclusion, “The combination of pembrolizumab and low-dose ipilimumab is tolerable, and provided an ORR that is comparable to that previously reported for nivolumab and full-dose ipilimumab.” Efficacy, safety, and biomarkers will be further analyzed in a full expansion cohort of 153 patients. However, let’s keep in mind that both combinations of ipilimumab with nivolumab or with ipilimumab have a high rate of AEs.
In Oncosec's combination trial with ImmunoPulse IL-12, pembrolizumab will be administered at 200mg flat dose every 3 weeks, which means that unless every patient weights an average of 100kg, pembrolizumab will be given at higher rates than the ones being used with the ipilimumab/pembrolizumab combination . And if in fact it lessens drastically the adverse events, while improving results with that slight increase in dosage and incorporation of IL-12, there will be no hesitation in moving forward and using the ImmunoPulse platform in a combination that might already be approved using pembrolizumab.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM